nikethamide has been researched along with Brain Neoplasms in 1 studies
Nikethamide: A central nervous system stimulant. It was formerly used in the treatment of barbiturate overdose but is now considered to be of no value for such purposes and may be dangerous. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1229)
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elkharraz, K | 1 |
| Faisant, N | 1 |
| Guse, C | 1 |
| Siepmann, F | 1 |
| Arica-Yegin, B | 1 |
| Oger, JM | 1 |
| Gust, R | 1 |
| Goepferich, A | 1 |
| Benoit, JP | 1 |
| Siepmann, J | 1 |
1 other study available for nikethamide and Brain Neoplasms
| Article | Year |
|---|---|
Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Drug Carriers; Drug Compounding; Drug Implants; | 2006 |